Page last updated: 2024-10-23

5-methoxypsoralen and Granulocytic Leukemia, Chronic

5-methoxypsoralen has been researched along with Granulocytic Leukemia, Chronic in 1 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salvador, A1
Dall'Acqua, S1
Sardo, MS1
Caffieri, S1
Vedaldi, D1
Dall'Acqua, F1
Borgatti, M1
Zuccato, C1
Bianchi, N1
Gambari, R1

Other Studies

1 other study available for 5-methoxypsoralen and Granulocytic Leukemia, Chronic

ArticleYear
Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.
    ChemMedChem, 2010, Sep-03, Volume: 5, Issue:9

    Topics: 5-Methoxypsoralen; Antineoplastic Agents; Cell Differentiation; Erythroid Cells; Heterocyclic Compou

2010